Literature DB >> 23007601

A dysphoric-like state during early withdrawal from extended access to methamphetamine self-administration in rats.

Choon-Gon Jang1, Timothy Whitfield, Gery Schulteis, George F Koob, Sunmee Wee.   

Abstract

RATIONALE: Negative emotional states during drug withdrawal may contribute to compulsive drug intake and seeking in humans. Studies suggest that extended access to methamphetamine induces compulsive drug intake in rats.
OBJECTIVE: The present study tested the hypothesis that compulsive methamphetamine intake in rats with extended access is associated with negative emotional states during drug withdrawal.
METHODS: Rats with short (1 h, ShA) and extended access (6 h, LgA) to methamphetamine self-administration (0.05 mg/kg/infusion) were tested for reward thresholds using intracranial self-stimulation (ICSS). Different groups of ShA and LgA rats were examined for depression-like and anxiety-like states in the novelty-suppressed feeding, open field, defensive burying, and forced swim tests.
RESULTS: With extended access, ICSS thresholds gradually increased, which was correlated with the increase of drug intake. During drug withdrawal, the increased ICSS thresholds returned to levels observed before exposure to extended access to methamphetamine. Upon re-exposure to extended access to methamphetamine, ICSS thresholds showed a more rapid escalation than during the initial exposure. LgA rats showed a longer latency to approach chow in the center of a novel field and remained immobile longer in the forced swim test than ShA rats did during early withdrawal. In contrast, ShA rats actively buried an aversive shock probe whereas LgA rats remained immobile in the defensive burying test.
CONCLUSION: The data suggest that extended access to methamphetamine produces a more depressive-like state than anxiety-like state in rats during early withdrawal.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23007601      PMCID: PMC3547144          DOI: 10.1007/s00213-012-2864-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  44 in total

Review 1.  Drug addiction, dysregulation of reward, and allostasis.

Authors:  G F Koob; M Le Moal
Journal:  Neuropsychopharmacology       Date:  2001-02       Impact factor: 7.853

Review 2.  Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test.

Authors:  Stephanie C Dulawa; Rene Hen
Journal:  Neurosci Biobehav Rev       Date:  2005       Impact factor: 8.989

Review 3.  Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure.

Authors:  David H Epstein; Kenzie L Preston; Jane Stewart; Yavin Shaham
Journal:  Psychopharmacology (Berl)       Date:  2006-09-22       Impact factor: 4.530

Review 4.  A range of research-based pharmacotherapies for addiction.

Authors:  C P O'Brien
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

5.  Dramatic decreases in brain reward function during nicotine withdrawal.

Authors:  M P Epping-Jordan; S S Watkins; G F Koob; A Markou
Journal:  Nature       Date:  1998-05-07       Impact factor: 49.962

6.  Postcocaine anhedonia. An animal model of cocaine withdrawal.

Authors:  A Markou; G F Koob
Journal:  Neuropsychopharmacology       Date:  1991-01       Impact factor: 7.853

7.  Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration.

Authors:  Sunmee Wee; Zhixia Wang; William L Woolverton; Luigi Pulvirenti; George F Koob
Journal:  Neuropsychopharmacology       Date:  2007-02-28       Impact factor: 7.853

8.  A sensitive open field measure of anxiolytic drug activity.

Authors:  D R Britton; K T Britton
Journal:  Pharmacol Biochem Behav       Date:  1981-10       Impact factor: 3.533

9.  Adult hippocampal neurogenesis buffers stress responses and depressive behaviour.

Authors:  Jason S Snyder; Amélie Soumier; Michelle Brewer; James Pickel; Heather A Cameron
Journal:  Nature       Date:  2011-08-03       Impact factor: 49.962

10.  CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior.

Authors:  Michael R Bruchas; Benjamin B Land; Julia C Lemos; Charles Chavkin
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

View more
  34 in total

1.  Intravenous self-administration of entactogen-class stimulants in male rats.

Authors:  Sophia A Vandewater; Kevin M Creehan; Michael A Taffe
Journal:  Neuropharmacology       Date:  2015-08-21       Impact factor: 5.250

Review 2.  The development and maintenance of drug addiction.

Authors:  Roy A Wise; George F Koob
Journal:  Neuropsychopharmacology       Date:  2013-10-11       Impact factor: 7.853

Review 3.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

Review 4.  Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.

Authors:  George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2017-01-03       Impact factor: 4.530

5.  Timing of amphetamine exposure in relation to puberty onset determines its effects on anhedonia, exploratory behavior, and dopamine D1 receptor expression in young adulthood.

Authors:  Shuo Kang; Mariah M Wu; Roberto Galvez; Joshua M Gulley
Journal:  Neuroscience       Date:  2016-10-01       Impact factor: 3.590

6.  Increases in compulsivity, inflammation, and neural injury in HIV transgenic rats with escalated methamphetamine self-administration under extended-access conditions.

Authors:  Giordano de Guglielmo; Yu Fu; Jihuan Chen; Estefania Larrosa; Ivy Hoang; Tomoya Kawamura; Irene Lorrai; Barry Zorman; Joseph Bryant; Olivier George; Pavel Sumazin; Celine Lefebvre; Vez Repunte-Canonigo; Pietro Paolo Sanna
Journal:  Brain Res       Date:  2019-10-09       Impact factor: 3.252

7.  Neurochemical and behavioral comparisons of contingent and non-contingent methamphetamine exposure following binge or yoked long-access self-administration paradigms.

Authors:  Catherine A Schweppe; Caitlin Burzynski; Subramaniam Jayanthi; Bruce Ladenheim; Jean Lud Cadet; Eliot L Gardner; Zheng-Xiong Xi; Henriette van Praag; Amy Hauck Newman; Thomas M Keck
Journal:  Psychopharmacology (Berl)       Date:  2020-05-09       Impact factor: 4.530

8.  Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats.

Authors:  Brendan J Tunstall; Chelsea P Ho; Jianjing Cao; Janaína C M Vendruscolo; Brooke E Schmeichel; Rachel D Slack; Gianluigi Tanda; Alexandra J Gadiano; Rana Rais; Barbara S Slusher; George F Koob; Amy H Newman; Leandro F Vendruscolo
Journal:  Neuropharmacology       Date:  2017-12-05       Impact factor: 5.250

9.  Incubation of methamphetamine and palatable food craving after punishment-induced abstinence.

Authors:  Irina N Krasnova; Nathan J Marchant; Bruce Ladenheim; Michael T McCoy; Leigh V Panlilio; Jennifer M Bossert; Yavin Shaham; Jean L Cadet
Journal:  Neuropsychopharmacology       Date:  2014-03-03       Impact factor: 7.853

10.  κ Opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake.

Authors:  Timothy W Whitfield; Joel E Schlosburg; Sunmee Wee; Adam Gould; Olivier George; Yanabel Grant; Eva R Zamora-Martinez; Scott Edwards; Elena Crawford; Leandro F Vendruscolo; George F Koob
Journal:  J Neurosci       Date:  2015-03-11       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.